Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for manufacturing partners to help boost production. Through a series of licensing agreements with generics makers, Gilead has taken the first steps to build that network. Gilead signed nonexclusive licensing agreements with five generic drug makers operating in India and… Read More »
